{"cik":1832168,"entityName":"Longboard Pharmaceuticals, Inc.","facts":{"dei":{"EntityCommonStockSharesOutstanding":{"label":"Entity Common Stock, Shares Outstanding","description":"Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.","units":{"shares":[{"end":"2021-05-05","val":17215350,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}}},"us-gaap":{"AccountsPayableCurrent":{"label":"Accounts Payable, Current","description":"Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-12-31","val":1213000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":2019000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"AccruedEmployeeBenefitsCurrent":{"label":"Accrued Employee Benefits, Current","description":"Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-12-31","val":161000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":275000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"AccruedLiabilitiesCurrent":{"label":"Accrued Liabilities, Current","description":"Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-12-31","val":845000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":699000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"AccruedProfessionalFeesCurrent":{"label":"Accrued Professional Fees, Current","description":"Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-12-31","val":115000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":0,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"AdditionalPaidInCapitalCommonStock":{"label":"Additional Paid in Capital, Common Stock","description":"Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.","units":{"USD":[{"end":"2020-12-31","val":11708000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":139684000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue":{"label":"APIC, Share-based Payment Arrangement, Increase for Cost Recognition","description":"Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.","units":{"USD":[{"start":"2020-01-03","end":"2020-03-31","val":95000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":333000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1"}]}},"AllocatedShareBasedCompensationExpense":{"label":"Share-based Payment Arrangement, Expense","description":"Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.","units":{"USD":[{"start":"2020-01-03","end":"2020-03-31","val":95000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":333000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1"}]}},"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount":{"label":"Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount","description":"Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.","units":{"shares":[{"start":"2021-01-01","end":"2021-03-31","val":1596606,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1"}]}},"Assets":{"label":"Assets","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2020-12-31","val":56238000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":123630000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"AssetsCurrent":{"label":"Assets, Current","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2020-12-31","val":55362000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":123630000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"CashAndCashEquivalentsAtCarryingValue":{"label":"Cash and Cash Equivalents, at Carrying Value","description":"Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.","units":{"USD":[{"end":"2020-12-31","val":55316000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":120851000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"CashAndCashEquivalentsPeriodIncreaseDecrease":{"label":"Cash and Cash Equivalents, Period Increase (Decrease)","description":"Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":65535000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1"}]}},"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents":{"label":"Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents","description":"Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.","units":{"USD":[{"end":"2020-12-31","val":55316000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":120851000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"CommonStockParOrStatedValuePerShare":{"label":"Common Stock, Par or Stated Value Per Share","description":"Face amount or stated value per share of common stock.","units":{"USD/shares":[{"end":"2020-12-31","val":0.0001,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":0.0001,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"CommonStockSharesAuthorized":{"label":"Common Stock, Shares Authorized","description":"The maximum number of common shares permitted to be issued by an entity's charter and bylaws.","units":{"shares":[{"end":"2020-12-31","val":10500000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":300000000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"CommonStockSharesIssued":{"label":"Common Stock, Shares, Issued","description":"Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.","units":{"shares":[{"end":"2020-12-31","val":3840540,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":12939140,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"CommonStockSharesOutstanding":{"label":"Common Stock, Shares, Outstanding","description":"Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.","units":{"shares":[{"end":"2020-12-31","val":3840540,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":12939140,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"CommonStockValue":{"label":"Common Stock, Value, Issued","description":"Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.","units":{"USD":[{"end":"2021-03-31","val":1000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"ConversionOfStockAmountIssued1":{"label":"Conversion of Stock, Amount Issued","description":"\"The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"\"Part noncash\"\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.\"","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":55795000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1"}]}},"DeferredCostsCurrent":{"label":"Deferred Costs, Current","description":"Sum of the carrying amounts as of the balance sheet date of deferred costs capitalized at the end of the reporting period that are expected to be charged against earnings within one year or the normal operating cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":876000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":0,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"EarningsPerShareBasicAndDiluted":{"label":"Earnings Per Share, Basic and Diluted","description":"The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.","units":{"USD/shares":[{"start":"2020-01-03","end":"2020-03-31","val":-0.05,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-0.84,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1"}]}},"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized":{"label":"Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount","description":"Amount of cost not yet recognized for nonvested award under share-based payment arrangement.","units":{"USD":[{"end":"2021-03-31","val":5500000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"ForeclosedAssets":{"label":"Repossessed Assets","description":"Carrying amount as of the balance sheet date of all assets obtained in full or partial satisfaction of a debt arrangement through foreclosure proceedings or defeasance; includes real and personal property; equity interests in corporations, partnerships, and joint ventures; and beneficial interests in trusts.","units":{"USD":[{"end":"2021-03-31","val":119600000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"GeneralAndAdministrativeExpense":{"label":"General and Administrative Expense","description":"The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.","units":{"USD":[{"start":"2020-01-03","end":"2020-03-31","val":115000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":1305000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1"}]}},"IncreaseDecreaseInAccountsPayable":{"label":"Increase (Decrease) in Accounts Payable","description":"The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":275000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1"}]}},"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities":{"label":"Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities","description":"Amount of increase (decrease) in accrued expenses, and obligations classified as other.","units":{"USD":[{"start":"2020-01-03","end":"2020-03-31","val":5000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-172000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1"}]}},"IncreaseDecreaseInAccruedSalaries":{"label":"Increase (Decrease) in Accrued Salaries","description":"The increase (decrease) during the period in accrued salaries.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":9000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":115000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1"}]}},"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets":{"label":"Increase (Decrease) in Prepaid Expense and Other Assets","description":"Amount of increase (decrease) in prepaid expenses, and assets classified as other.","units":{"USD":[{"start":"2020-01-03","end":"2020-03-31","val":1000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":2733000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1"}]}},"InterestIncomeExpenseNonoperatingNet":{"label":"Interest Income (Expense), Nonoperating, Net","description":"The net amount of nonoperating interest income (expense).","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":4000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1"}]}},"LiabilitiesAndStockholdersEquity":{"label":"Liabilities and Equity","description":"Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.","units":{"USD":[{"end":"2020-12-31","val":56238000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":123630000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"LiabilitiesCurrent":{"label":"Liabilities, Current","description":"Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":3135000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":4044000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"NetCashProvidedByUsedInFinancingActivities":{"label":"Net Cash Provided by (Used in) Financing Activities","description":"Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.","units":{"USD":[{"start":"2020-01-03","end":"2020-03-31","val":39000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":73281000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1"}]}},"NetCashProvidedByUsedInOperatingActivities":{"label":"Net Cash Provided by (Used in) Operating Activities","description":"Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.","units":{"USD":[{"start":"2020-01-03","end":"2020-03-31","val":-39000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-7746000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1"}]}},"NetIncomeLoss":{"label":"Net Income (Loss) Attributable to Parent","description":"The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.","units":{"USD":[{"start":"2020-01-03","end":"2020-03-31","val":-174000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-5699000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1"}]}},"OperatingExpenses":{"label":"Operating Expenses","description":"Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.","units":{"USD":[{"start":"2020-01-03","end":"2020-03-31","val":174000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":5703000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1"}]}},"OperatingIncomeLoss":{"label":"Operating Income (Loss)","description":"The net result for the period of deducting operating expenses from operating revenues.","units":{"USD":[{"start":"2020-01-03","end":"2020-03-31","val":-174000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-5703000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1"}]}},"OperatingLeasesRentExpenseNet":{"label":"Operating Leases, Rent Expense, Net","description":"Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":1000000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":3000000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1"}]}},"OtherAccruedLiabilitiesCurrent":{"label":"Other Accrued Liabilities, Current","description":"Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":91000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":35000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"PartnersCapitalAccountContributions":{"label":"Partners' Capital Account, Contributions","description":"Total contributions made by each class of partners (i.e., general, limited and preferred partners).","units":{"USD":[{"start":"2020-01-03","end":"2020-03-31","val":39000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q1"}]}},"PaymentsForRent":{"label":"Payments for Rent","description":"Cash payments to lessor's for use of assets under operating leases.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":1000000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1"}]}},"PaymentsForRepurchaseOfInitialPublicOffering":{"label":"Payments for Repurchase of Initial Public Offering","description":"The cash outflow associated with the repurchase of amount received from entity's first offering of stock to the public.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":6718000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1"}]}},"PaymentsOfStockIssuanceCosts":{"label":"Payments of Stock Issuance Costs","description":"The cash outflow for cost incurred directly with the issuance of an equity security.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":1000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1"}]}},"PreferredStockParOrStatedValuePerShare":{"label":"Preferred Stock, Par or Stated Value Per Share","description":"Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.","units":{"USD/shares":[{"end":"2020-12-31","val":0.0001,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":0.0001,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"PreferredStockSharesAuthorized":{"label":"Preferred Stock, Shares Authorized","description":"The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.","units":{"shares":[{"end":"2020-12-31","val":0,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":10000000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"PreferredStockSharesIssued":{"label":"Preferred Stock, Shares Issued","description":"Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.","units":{"shares":[{"end":"2020-12-31","val":0,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":0,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"PreferredStockSharesOutstanding":{"label":"Preferred Stock, Shares Outstanding","description":"Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.","units":{"shares":[{"end":"2020-12-31","val":0,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":0,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"PrepaidExpenseAndOtherAssetsCurrent":{"label":"Prepaid Expense and Other Assets, Current","description":"Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":46000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":2779000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"ProceedsFromContributedCapital":{"label":"Proceeds from Contributed Capital","description":"The cash inflow associated with the amount received by a corporation from a shareholder during the period.","units":{"USD":[{"start":"2020-01-01","end":"2020-12-31","val":3200000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020"}]}},"ProceedsFromIssuanceInitialPublicOffering":{"label":"Proceeds from Issuance Initial Public Offering","description":"The cash inflow associated with the amount received from entity's first offering of stock to the public.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":80000000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1"}]}},"ProceedsFromIssuanceOfCommonStock":{"label":"Proceeds from Issuance of Common Stock","description":"The cash inflow from the additional capital contribution to the entity.","units":{"USD":[{"start":"2020-01-03","end":"2020-03-31","val":39000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q1"}]}},"ProfitLoss":{"label":"Net Income (Loss), Including Portion Attributable to Noncontrolling Interest","description":"The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.","units":{"USD":[{"start":"2020-01-03","end":"2020-03-31","val":-174000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":-5699000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1"}]}},"ResearchAndDevelopmentExpense":{"label":"Research and Development Expense","description":"The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.","units":{"USD":[{"start":"2020-01-03","end":"2020-03-31","val":59000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":4398000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1"}]}},"RetainedEarningsAccumulatedDeficit":{"label":"Retained Earnings (Accumulated Deficit)","description":"The cumulative amount of the reporting entity's undistributed earnings or deficit.","units":{"USD":[{"end":"2020-12-31","val":-14400000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":-20099000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"ShareBasedCompensation":{"label":"Share-based Payment Arrangement, Noncash Expense","description":"Amount of noncash expense for share-based payment arrangement.","units":{"USD":[{"start":"2020-01-03","end":"2020-03-31","val":95000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":333000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate","description":"The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.","units":{"pure":[{"start":"2021-01-01","end":"2021-03-31","val":0,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate","description":"The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.","units":{"pure":[{"start":"2021-01-01","end":"2021-03-31","val":0.7387,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate","description":"The risk-free interest rate assumption that is used in valuing an option on its own shares.","units":{"pure":[{"start":"2021-01-01","end":"2021-03-31","val":0.0084,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number","description":"The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.","units":{"shares":[{"end":"2021-03-31","val":356187,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price","description":"The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.","units":{"USD/shares":[{"end":"2021-03-31","val":3.18,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross","description":"Gross number of share options (or share units) granted during the period.","units":{"shares":[{"start":"2021-01-01","end":"2021-03-31","val":374892,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value","description":"The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.","units":{"USD/shares":[{"start":"2021-01-01","end":"2021-03-31","val":7.8,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value","description":"Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.","units":{"USD":[{"end":"2021-03-31","val":12900000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number","description":"Number of options outstanding, including both vested and non-vested options.","units":{"shares":[{"end":"2020-12-31","val":873264,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":1248156,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price","description":"Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.","units":{"USD/shares":[{"end":"2020-12-31","val":3.42,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":6.03,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number","description":"Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.","units":{"shares":[{"end":"2021-03-31","val":7737,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price","description":"Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.","units":{"USD/shares":[{"start":"2021-01-01","end":"2021-03-31","val":12.1,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1"}]}},"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value","description":"Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.","units":{"USD":[{"end":"2021-03-31","val":4700000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"SharePrice":{"label":"Share Price","description":"Price of a single share of a number of saleable stocks of a company.","units":{"USD/shares":[{"end":"2021-03-31","val":12.1,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"StockholdersEquity":{"label":"Stockholders' Equity Attributable to Parent","description":"Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.","units":{"USD":[{"end":"2020-03-31","val":-40000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q1I"},{"end":"2020-12-31","val":-2692000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":119586000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"StockholdersEquityNoteStockSplitConversionRatio1":{"label":"Stockholders' Equity Note, Stock Split, Conversion Ratio","description":"Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.","units":{"pure":[{"start":"2020-10-25","end":"2020-10-27","val":2783,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q3I"},{"start":"2021-03-03","end":"2021-03-05","val":1.38,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"StockIssuedDuringPeriodSharesPeriodIncreaseDecrease":{"label":"Stock Issued During Period, Shares, Period Increase (Decrease)","description":"The increase (decrease) during the period in the number of shares issued.","units":{"shares":[{"start":"2021-01-01","end":"2021-03-31","val":2970000,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1"}]}},"StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased":{"label":"Stock Repurchase Program, Number of Shares Authorized to be Repurchased","description":"The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.","units":{"shares":[{"end":"2020-12-31","val":348450,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q4I"},{"end":"2021-03-31","val":348450,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1I"}]}},"WeightedAverageNumberOfShareOutstandingBasicAndDiluted":{"label":"Weighted Average Number of Shares Outstanding, Basic and Diluted","description":"Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).","units":{"shares":[{"start":"2020-01-03","end":"2020-03-31","val":3711084,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2020Q1"},{"start":"2021-01-01","end":"2021-03-31","val":6810407,"accn":"0000950170-21-000164","fy":2021,"fp":"Q1","form":"10-Q","filed":"2021-05-10","frame":"CY2021Q1"}]}}}}}